Post-marketing safety of panitumumab: a real-world pharmacovigilance study by Heli Wen (20459923)

“…Ileus was highlighted as a novel ADR in gastrointestinal disorders, with no significant age or sex differences.…”

A Revealed Preference Approach to Identification and Inference in Producer-Consumer Models by Charles Gauthier (1451917)

“…Using data on shopping expenditures and shopping intensity from the NielsenIQ Homescan Dataset, I show that a doubling of shopping intensity decreases prices paid by about <math><mrow><mn>15</mn><mi>%</mi></mrow></math>. …”

Table 1_Does adding ginger extract to a preoperative carbohydrate drink improve outcomes in enhanced recovery after elective neuro-oncologic craniotomy? A randomized controlled tri... by Anukoon Kaewborisutsakul (12988303)

“…The incidence of PONV did not significantly decrease (25% vs. 37.5%; p = 0.534), but vomiting episodes were significantly reduced (6 vs. 23 episodes; p = 0.003). …”

Impact of mobility in a three-region system with heterogeneous epidemic conditions. by Mousumi Roy (8869412)

“…These simulations underscore that both human mobility and regional epidemic status jointly shape disease transmission dynamics. Mobility has a significant impact in heterogeneous epidemic scenarios, where differences in transmission intensity across regions can lead to outbreaks in low-risk areas through population movement. …”

<b><i>Assessment of Diseases’ Prevalence, Nutrition and Associated Factors in a Conflict-Affected Region: A Study in Leepa Valley, Azad Jammu and Kashmir, Pakistan</i></b> by Zoha Khan (19100603)

“…Objectives: To assess general health and nutritional status, any prevailing diseases and associated factors in residents of the Conflict-Affected Region of Leepa Valley, Azad Jammu and Kashmir, Pakistan. Methodology: A cross-sectional study was executed by circulating a self-structured questionnaire among the patients at a Medical Camp in Leepa as convenient sampling. …”

Image 1_Ivarmacitinib reduces the need for adding/escalating medications in moderate-to-severe rheumatoid arthritis patients: a post hoc analysis from a phase III trial.tif by Huaxiang Liu (322464)

“…</p>Conclusion<p>Ivarmacitinib significantly reduces the need for adding/escalating medications compared to placebo, thereby potentially decreasing treatment burden. …”

S1 Data - by Ergang Wang (1459321)

“…Meanwhile, plant extract-related treatments significantly increased plant physiological properties and TP (Total protein) content, and decreased the content of MDA (malondialdehyde) by 15.70% -36.59% and PRO (proline) by 30.13% -148.44%. …”

Supplementary file 1_Feasibility of repetitive transcranial magnetic stimulation on non-motor symptoms of spinocerebellar ataxia type 3: a secondary analysis of a randomized clinic... by Hua Wu (2707)

“…</p>Results<p>The results disclosed significant time effects for all the outcomes with post hoc comparisons showing differences of baseline and post-treatment evaluation, with decreases for PSQI, AIS, HARS, and HDRS as well as increase for MMSE and MoCA. …”

Image 2_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …”

Table 2_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …”

Table 1_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …”

Image 1_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …”

Table 4_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …”

Table 3_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …”

Table 5_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …”

Classification of panels after the impact test. by Tek Raj Gyawali (20550560)

“…Panels reinforced with thinner PVA fibers exhibited superior performance in resisting compressive and impact loads. This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

XXXX. by Tek Raj Gyawali (20550560)

“…Panels reinforced with thinner PVA fibers exhibited superior performance in resisting compressive and impact loads. This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

Compounds of Type III Portland cement. by Tek Raj Gyawali (20550560)

“…Panels reinforced with thinner PVA fibers exhibited superior performance in resisting compressive and impact loads. This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

XXXX. by Tek Raj Gyawali (20550560)

“…Panels reinforced with thinner PVA fibers exhibited superior performance in resisting compressive and impact loads. This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

Impact test procedure on panel. by Tek Raj Gyawali (20550560)

“…Panels reinforced with thinner PVA fibers exhibited superior performance in resisting compressive and impact loads. This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”